RxDoctor Payments Data
★ My doctorsLook up a doctor →

Julie Krystal

Pediatric Hematology-Oncology · New Hyde Park, NYNPI 1689952269

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,888 of the $4,538 with a category attached, or 63.6%. Every reported general payment came from a single manufacturer, Day One Biopharmaceuticals.

$4,538in general payments, 2019–2025

Across 2 payments — averaging $2268.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Day One Biopharmaceuticals$5K
$1,086,659in research payments, 2019–2025

Across 126 payments — averaging $8624.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Astrazeneca UK Limited$577K
  • Novartis$251K
  • Merck$92K
  • Pfizer$85K
  • Eli Lilly$81K

What the payments were for

  • Consulting fees$1,65036%
  • Speaking & faculty fees$2,88864%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Day One Biopharmaceuticals2$4,538

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,538 in reported general payments places this provider in the 75th percentile of 196 pediatric hematology-oncology providers in New York.

See all pediatric hematology-oncology providers in New York →

Other pediatric hematology-oncology in New Hyde Park

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →